Updated Jul 16, 2026
Volpone John is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
John Volpone is the President of X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing therapies for rare diseases of the immune system. He has been involved in the company's operations as it works on innovative treatments such as mavorixafor.
| Role | President |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-08-12 | XFOR | X4 Pharmaceuticals, Inc | A — Grant or award | 289.9K | $0.00 |
John Volpone is the President of X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing therapies for rare diseases of the immune system. He has been involved in the company's operations as it works on innovative treatments such as mavorixafor.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Volpone John profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.